Latest filing published 02 Apr 2024 for TELA Bio, Inc., €856.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Peter C. Murphy: trading record in brief
Peter C. Murphy, listed as senior executive, appears in our data through filings on TELA Bio, Inc. shares, published by SEC (Form 4). The record holds 13 filings, for trades running from 24 February 2021 to 31 March 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 2 April 2024 came the latest disclosure, a share grant for €856 in TELA Bio, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Peter C. Murphy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 163 shares@ US$5.676.1% of flowCommon StockSEC:0001062993-24-007839:0
- 13,200 shares0Common StockSEC:0001062993-24-004574:0
- 163 shares@ US$10.6411.3% of flowCommon StockSEC:0001062993-23-008666:0
- 16,800 shares0Common StockSEC:0001062993-23-005027:0
- 163 shares@ US$11.6312.1% of flowCommon StockSEC:0001062993-22-009228:0
- 939 shares@ US$11.9870.5% of flowCommon StockSEC:0001062993-22-005912:0
- 10,800 shares0Common StockSEC:0001062993-22-005775:0
7 of 7 declarations
